Value Investor Clifford Sosin, founder and manager of CAS Investment Partners, runs a concentrated portfolio -- as of Q2's close the fund held only five positions. However, an equal-weighted portfolio of those five stocks is up 80% Year-to-date. The fund's top holding, online car retailer Carvana (CVNA),...
Activist hedge fund Glenview Capital filed a 13D on Bausch Health (BHC) after market hours Monday. The $13.3B fund, managed by Larry Robbins, disclosed a 5.9% stake in the pharmaceutical company. Bausch Health is now Glenview's #3 portfolio position. BHC shares closed at $18.79...
The ten most underrated hedge funds are not famous. But the managers running these funds have consistently generated exceptional returns despite (or maybe because) they fly under the radar. The stock picks of the managers on this list have handily outperformed most of the "wizards of...
Below is a list of the top ten most overrated hedge fund managers. Many of these guys (they're all men) have become celebrities, idolized by investors, just like movie stars or great athletes are in mainstream American society. And most of them made their billions -- and...
On June 17, EcoR1 Capital filed a 13G on Xencor Inc. (XNCR), disclosing the purchase of over 2M shares. EcoR1 now owns 8% of Xencor. The purchase makes XNCR the #1 position in EcoR1's $957M 13F portfolio. Xencor is a clinical-stage biopharmaceutical company...
For Akre Capital Management Founder Charles Akre, investment success is all about the power of compounding. As Akre puts it, "Many people think of us as a 'value investor' and others ask whether we are a value or a growth investor. We’ve started to say, we’re neither,...
At the Sohn San Francisco Investment Conference last year, Gil Simon of SoMa Equity Partners presented his best idea: SailPoint Technologies (SAIL). The Sohn conference is renowned as an annual event where hedge fund managers make market-moving presentations. Indeed, after Simon -- a rising star in the...
Leading health care-focused hedge fund Perceptive Advisors increased its Neptune Wellness (NEPT) stake by 37%, buying 5,000,000 shares. The fund made the disclosure via a 13G/A "passive" filing yesterday. Perceptive's purchase comes days after the Quebec-based cannabis extraction company announced a new partnership that will pay Neptune...
As we've written before, Abdiel Capital is all about focus. Managing partners Colin Moran and Geoffrey Gentile don't spread their bets around much -- they run a concentrated long book. Abdiel's 13F portfolio, disclosed last Friday, showed that the fund's $2.14B in long holdings was invested...
RA Capital has outperformed all other healthcare hedge funds over the past decade, based on 13F holdings. In fact, RA's 30.88% annualized return of it's equal-weighted top 20 long portfolio led all other hedge funds over that period. So, when RA manager Peter Kolchinsky discloses portfolio changes,...